Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3473 of 6351
-
Cord blood banked for sickle cell: a step toward future cures
Knowledge-focused CompletedThis study will determine the best ways to collect, process and store umbilical cord blood from babies with sickle cell disease, sickle cell trait and unaffected babies. Sickle cell disease is an abnormality of the hemoglobin in red blood cells that causes the cells to change sha…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Massive study aims to unlock genetic secrets of movement disorders
Knowledge-focused Recruiting nowThe goal of this protocol is to identify families with inherited movement disorders and evaluate disease manifestations to establish an accurate clinical diagnosis by using newest technological advances and investigate the underlying molecular mechanisms. Studies of inherited mov…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Gene hunt aims to unlock secrets of lung scarring
Knowledge-focused OngoingThis study is investigating the way the lung is damaged in a condition called pulmonary fibrosis. Research studies will be conducted on lung tissue obtained from an open lung biopsy performed by the subject's surgeon. The identification of unique genetic markers of scarred lung m…
Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Switching meds: a new hope for schizophrenia patients?
Disease control CompletedThis study will evaluate the effectiveness of switching medications in decreasing schizophrenia symptoms in individuals who are currently taking an antipsychotic medication for the treatment of schizophrenia.
Phase 4 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Blood test showdown: MCV vs. ferritin in iron overload treatment
Disease control OngoingThis study will evaluate the effectiveness of a test called MCV in guiding phlebotomy (blood drawing) therapy in patients with hemochromatosis an inherited disorder that causes too much iron to be absorbed by the intestine. The excess damages body tissues, most severely in the li…
Phase 2 • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Could new scans and duct wash detect breast cancer earlier in High-Risk women?
Knowledge-focused CompletedThis study will explore new screening methods for early detection of breast and ovarian cancer in women at high risk for these diseases, because they have an altered breast cancer 1 (BRCA1) or breast cancer 2 (BRCA2) gene. It will also try to determine if breast tissue characteri…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
Peer-led program aims to cut HIV/STD risk in drug-using women
Prevention CompletedWomen Teaching Women (WTW) is proposed by a team of Washington University investigators who have focused on HIV prevention efforts among out-of-treatment injecting drug users (IDUs) and crack cocaine users, since 1988. Our peer-delivered prevention model was successful in reducin…
Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated Jun 27, 2026 08:06 UTC
-
Job training boosts work success for schizophrenia patients
Symptom relief CompletedThis study will compare employment support with behavioral skills training to employment support alone in schizophrenia patients taking either risperidone or olanzapine to determine which is more effective in helping the patients maintain a job.
Phase 4 • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Scientists mine 1,100 patient records to spot thyroid cancer return risks
Knowledge-focused CompletedThe goal of this observational study is to identify demographic and clinicopathological factors associated with disease recurrence in adults with histologically confirmed papillary thyroid carcinoma (PTC) who achieved an initial disease-free status after primary treatment. The m…
Sponsor: University of Roma La Sapienza • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
20-Year study tests precision medicine for rare Brain-Skin disorders
Knowledge-focused CompletedThe goal of this observational study (retrospective multicenter cohort study) is to learn if precision medicine approaches-including genetic testing, targeted drugs, and coordinated care from multiple specialists-can improve health outcomes and lower medical costs for people with…
Sponsor: West China Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Which antibiotic is safer for blood infections? new study digs into Real-World data
Knowledge-focused OngoingBackground Methicillin-susceptible Staphylococcus aureus (MSSA) bacteraemia is a common and serious infection, associated with significant morbidity and high mortality rates. Antistaphylococcal penicillins (ASPs) have traditionally been recommended as the first-line treatment. Ho…
Sponsor: Central Hospital, Nancy, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Radiotherapy's true impact on breast cancer survival revealed
Knowledge-focused CompletedIn this study, using a large retrospective cohort, the investigators evaluate the impact of RT on disease-free survival and overall survival of patients with BC. The aim is to determine the true role of radiotherapy in improving patient outcomes and to provide a basis for designi…
Sponsor: Motamed Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Can common drugs tame a racing heart when you stand?
Symptom relief OngoingThis trial is designed to study the effects of various mechanistically unique medications in controlling excessive increases in heart rate with standing and in improving the symptoms of orthostatic intolerance in patients with this disorder.
Phase 1/2 • Sponsor: Satish R. Raj • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Scientists Re-Analyze old samples to unlock secrets of HER2-Low breast cancer
Knowledge-focused CompletedAlthough breast cancer remains one of the most common and fatal cancer types among women worldwide, earlier diagnosis and improved therapeutic approaches have led to decreased mortality over last years. Indeed, the use of HER2-targeted drugs has improved clinical outcomes for pat…
Sponsor: Hellenic Cooperative Oncology Group • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Scientists hunt for genetic clues to esophageal cancer in large study
Knowledge-focused CompletedThe overall goal of this project is to understand the role of genetics in the etiology and prevention of upper gastrointestinal cancer, primarily esophageal cancer, but also cancers of the gastric cardia and body. Esophageal cancer is the second most common cause of cancer death…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Study tests skipping extra treatment for early breast condition
Disease control CompletedThe purpose of this study is to determine if wide excision (surgical removal) alone is adequate treatment for small, grade 1 or 2 ductal carcinoma in situ (DCIS) of the breast.
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Cystinosis drug under Long-Term watch: could cysteamine be key?
Disease control Recruiting nowCystinosis is an inherited disease resulting in poor growth and kidney failure. There is no known cure for cystinosis, although kidney transplantation may help the renal failure and prolong survival. Both the kidney damage and growth failure are thought to be due to the accumulat…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Stem cell therapy explored for long COVID relief
Disease control Expanded access (ended)This is an Intermediate- Size Patient Population Expanded Access Protocol to evaluate the safety and efficacy of HB-adMSCs for the treatment of patients with Post-COVID-19 Syndrome. The investigational product will be an add-on treatment to the standard of care.
Sponsor: Hope Biosciences Research Foundation • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Drug access program offers hope for rare blood disorder patients
Disease control Expanded access (paused)The purpose of this post-trial access (PTA) program is to provide nipocalimab for the treatment of participants with Warm Autoimmune Hemolytic Anemia (wAIHA) who are experiencing clinical benefit after completing 28-weeks open-label extension in MOM-M281-006 (NCT04119050) study.
Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Own stem cells infused in spinal cord injury hope
Disease control Expanded access (ended)This study is expanded access to an Investigational New Drug (IND) for an individual patient with spinal cord injury (SCI) at cervical spine 5-6 (C 5-6) designed to provide access to autologous adipose-derived mesenchymal stem cells (HB-adMSCs)
Sponsor: Hope Biosciences LLC • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC